Logo: Finers Stephens Innocent

GO

ARE YOU BASED OUTSIDE THE UK?

Many international companies float on AIM.  We have a track record in advising them.  If you're considering Nasdaq as an alternative, click here to review our guide.

 
You can change the default text sizeSmall text sizeNormal text sizeLarge text sizeOrder here

If you are looking to float on AIM, the London Stock Exchange is the market for young growing companies, the team at FSI have the necessary experience and skills to help.

 

Nilam Statham provides 2 min overview of the new AIM Rule Book
Look closer

The AIM rules changed in February 2007 - click on the video file to your left for a two minute introduction.  Since the rule book changed FSI have been putting together handy checklists for our AIM listed clients, NOMADS and Brokers. If you would like to check your website is compliant with the new rules then email francesca.malone@fsilaw.com and we will send you a copy of the checklist.


OUR service:

  • one of the leading advisers to AIM companies: during the last 12 months the team advised on 9 AIM admissions listings, 10 secondary placings and 3 reverse takeovers
  • track record of floating companies on AIM since AIM's inception
  • extensive experience across multiple sectors
  • significant experience advising international companies floating on AIM
  • track record in advising issuers and nomads
  • proactive advice: website checklist a good example of how we identify issues for our clients and make them aware of the activities they need to undertake to comply

RECENT EXPERIENCE ADVISING:

  • Advising York Pharma on the conditional acquisition of Derms Development Limited for £17.5 million.  In conjunction, the team advised York Pharma on its £5.35 million fundraising by secondary placing
  • JM Finn Capital Markets Limited and City Financial Associates Limited in Hill Station's secondary placing of new Ordinary Shares on the AIM market
  • AIM listed client, Jelf Group Plc, on its acquisition of SPS Wellbeing Ltd for up to £10 million, a market leading specialist healthcare and group risk intermediary, and on a £20 million financing with The Royal Bank of Scotland Plc
  • Daniel Stewart & Company Plc, a nomad and broker, on the placing and admission of STM Group Plc to trading on AIM, raising gross funds of £7.5 million with a market capitalisation of £17.6 million
  • AIM listed client, York Pharma Plc, on the acquisition of Rosanto Pharmaceuticals Limited for £2.5 million together with a £5.25 million placing of new shares. York Pharma acquires, develops and markets products in the dermatological field.
  • CareCapital Group Plc (and its shareholders, including AXA Real Estate Investment Managers Limited) on a placing of existing and new shares and its admission to AIM. FSI also advised shareholder Asgard Real Estate Private Equity S.a.r.l, a Luxembourg company which is managed by AXA Real Estate Investment Managers Limited, on its £6 million disposal on admission. The market capitalisation of CareCapital Group Plc was approximately £23 million
  • JM Finn & Co Ltd, a nomad and broker, on the admission of Minoan Group Plc, a leisure resort development company, on its admission to AIM with a market capitalisation of £45 million
  • Daniel Stewart & Company Plc, nominated adviser and broker, on an £18 million secondary placing for AIM listed Accuma Group Plc
  • Nanotech Energy Plc on the acquisition of Impact Funding (UK) Limited, two placings raising £5.75 million and the admission of the enlarged group to trading on AIM
  • Interactive World Plc and David Sullivan on their £9.5 million placings and admission to trading on AIM with a market capitalisation of £28 million 
  • Top Ten Holdings Plc on the placing of new shares and a refinancing for £45.8 million
  • Top Ten Holdings Plc on the acquisition of Apollo Bingo for £11.1 million
  • Daniel Stewart & Company Plc on the acquisition by AIM listed Fairground Gaming Holdings Plc of the Spin Palace Group Plc for $65 million and a £6 million placing
  • City Financial Associates Limited, a nominated adviser, on the £3.9 million reverse takeover of Contemporary Enterprise Plc by Timegate Group Limited
  • Centurion Electronics Plc on a £2.5 million placing of new shares on AIM together with a refinancing
  • JM Finn & Co Ltd on placings for AIM listed ReGen Therapeutics Plc
  • Jelf Group Plc on its acquisition of Goss Group Ltd and a £7.3 million placing
  • Astek Group Plc on the acquisition of Astek Innovations Limited, a placing and admission to AIM
  • Daniel Stewart & Company Plc, a nominated adviser and broker, on the £2.8 million placing and admission to AIM of LitComp Plc
  • Daniel Stewart & Company Plc, a nominated adviser and broker, on the £4 million placing for AIM listed Chaco Resources Plc

quotation From what I've observed,  FSI and Sara Wax in particular, have been extremely impressive.  The whole team were excellent and provided a first class service.
Dr. Alan Segal, Chief Executive Office of Astek Group Plc

quotation FSI offered Asgard Real Estate Private Equity S.a.r.l a quality alternative to the City and delivered an excellent all round service.  Of particular note was corporate partner Ashley Reeback who led the team well and demonstrated a commercial and proactive approach.
Jonathon Ross-McNairn, Legal Associate, AXA Real Estate IM Opportunity Fund

quotation We've been with FSI since our flotation three years ago and have also sought their advice on various acquisitions. Nilam led the team involved in the acquisition of Rosanto Pharmaceuticals and I couldn't fault them. They kept the deal moving and driving it on. The team were spot on and it was a very happy and successful transaction.
Ian Harvey, Finance Director, York Pharma Plc

quotation We've been with FSI since our flotation three years ago and have also sought their advice on various acquisitions. Nilam led the team involved in the acquisition of Rosanto Pharmaceuticals and I couldn't fault them. They kept the deal moving and driving it on. The team were spot on and it was a very happy and successful transaction.
Ian Harvey, Finance Director, York Pharma Plc

 

quotation FSI are always available when we need them and they get deals done quickly and efficiently.  We are always confident of a successful outcome when we're working with them
Sam Smith, Managing Director and Head of Corporate Finance at JM Finn Capital Markets

THE DIRECTORIES SAY...

quotation Ashley Reeback heads the AIM team and makes his clients “feel safe when under the spotlight .”  His team cleared over 20 AIM related transactions in the last year for such clients as YooMedia and Top Ten Holdings. The remainder of the team’s workflow is made up by general corporate advice to the firm’s vibrant entrepreneurial, insurance and financial institution clients.
Chambers 2007, A Client's Guide to the Legal Profession

More good medicine:  FSI advise York Pharma on their second acquisition this year

We have recently advised longstanding AIM listed client, York Pharma on the conditional acquisition of Derms Development Limited and on fundraising by secondary placing.  To find out more, click here

What have we been up to?

Click here to check out more of our latest deals


Assessing our experience and approach? Give me a call:

Ashley Reeback

Ashley Reeback